AR007294A1 - NEW USE OF CYSTINE DERIVATIVES - Google Patents

NEW USE OF CYSTINE DERIVATIVES

Info

Publication number
AR007294A1
AR007294A1 ARP970102236A ARP970102236A AR007294A1 AR 007294 A1 AR007294 A1 AR 007294A1 AR P970102236 A ARP970102236 A AR P970102236A AR P970102236 A ARP970102236 A AR P970102236A AR 007294 A1 AR007294 A1 AR 007294A1
Authority
AR
Argentina
Prior art keywords
new use
cystine derivatives
pharmaceutically acceptable
cystine
derivatives
Prior art date
Application number
ARP970102236A
Other languages
Spanish (es)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AR007294A1 publication Critical patent/AR007294A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]

Abstract

Uso de un derivado de cistina, o una sal farmacéuticamente acptable de la misma, en sus formas esteroiseomericas individuales, o en una mezcla deesteroisómeros, para la preparación de un medicamento para el tratamiento de infecciones crónicas dehepatitis B y/o C que comprende una cantidad efectivade los derivados mencionados con o sin un vehículo farmacéuticamente aceptable.Use of a cystine derivative, or a pharmaceutically acceptable salt thereof, in its individual steroiseomeric forms, or in a mixture of steroisomers, for the preparation of a medicament for the treatment of chronic hepatitis B and / or C infections comprising an amount of the derivatives mentioned with or without a pharmaceutically acceptable carrier.

ARP970102236A 1996-06-06 1997-05-26 NEW USE OF CYSTINE DERIVATIVES AR007294A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602262A SE9602262D0 (en) 1996-06-06 1996-06-06 New use of cystine derivatives

Publications (1)

Publication Number Publication Date
AR007294A1 true AR007294A1 (en) 1999-10-27

Family

ID=20402927

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102236A AR007294A1 (en) 1996-06-06 1997-05-26 NEW USE OF CYSTINE DERIVATIVES

Country Status (6)

Country Link
AR (1) AR007294A1 (en)
AU (1) AU3114197A (en)
ID (1) ID17383A (en)
SE (1) SE9602262D0 (en)
WO (1) WO1997046229A1 (en)
ZA (1) ZA974679B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3988014B2 (en) * 2000-02-02 2007-10-10 味の素株式会社 Antiviral agent
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
WO2009100431A1 (en) * 2008-02-07 2009-08-13 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
JP6814312B1 (en) * 2020-02-05 2021-01-13 株式会社タイショーテクノス How to impart antiviral properties to antiviral agents and articles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981003330A1 (en) * 1980-05-13 1981-11-26 Mitsubishi Chem Ind Cysteine derivative and production thereof
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
SE9103572D0 (en) * 1991-11-29 1991-11-29 Astra Ab ORGANIC SALTS OF N, N'-DIACETYL CYSTINE

Also Published As

Publication number Publication date
SE9602262D0 (en) 1996-06-06
AU3114197A (en) 1998-01-05
ID17383A (en) 1997-12-24
WO1997046229A1 (en) 1997-12-11
ZA974679B (en) 1997-12-08

Similar Documents

Publication Publication Date Title
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
PA8539901A1 (en) NOVEDOUS O-DESMETIL-VENLAFAXINE SUCCINATE SALT
ITRM920155A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINO) ETHYL-N-METHYL-1H-INDOL-5-METHANSULFONAMIDE, AND RELATED PROCEDURE FOR THE PREPARATION AND TREATMENT OF MAMMALS WITH IT.
AR017979A1 (en) PHARMACEUTICAL FORMULATIONS OF EPOTILONES, METHOD FOR THE PREPARATION AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
ES2186667T3 (en) NUCLEOSIDE ANALOGS OF 1,3-OXATIOLANE.
ES2083668T3 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSID ANALOGS.
ES2090713T3 (en) ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE.
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
AR047191A1 (en) METHODS OF TREATMENT OF HEPATIC FIBROSIS
ES2051678T1 (en) DERIVATIVES OF 5-OXO-L-PROLINE AND PHARMACEUTICAL USE THEREOF.
AR002157A1 (en) USE OF AN EFFECTIVE IMMUNIZING DOSE OF LIVE EIMERIA ESPOROZOITES OR MEROZOITES, OR A MIXTURE OF THE SAME
MX9202152A (en) DERIVATIVES OF INDOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
IT1231012B (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING NAC.
ES2062043T3 (en) TOPIC FORMULATIONS AND TRANSDERMIC SUPPLY SYSTEMS CONTAINING 1-ISOBUTYL-1H-IMIDAZO (4,5-C) -QUINOLEIN-4-AMINE.
MX9300399A (en) HETEROTRICICLIC DERIVATIVES.
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
MX9201058A (en) CYCLICAL DERIVATIVES OF CETAL, PROCEDURE FOR SUPREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
ES2187489T3 (en) DICLOFENAC BASED PHARMACEUTICAL COMPOSITIONS.
AR007294A1 (en) NEW USE OF CYSTINE DERIVATIVES
ITMI912509A0 (en) USE OF NIMESULIDE IN THE TREATMENT OF CATARACT
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
ES2072386T3 (en) DERIVATIVES OF PENCICLOVIR FOR THE TREATMENT OF HEPATITIS-B INFECTIONS.
AR002191A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS IN THE FORM OF SOLUTION, PROCEDURE FOR ITS PREPARATION